Today: 10 June 2026
Tesla stock ticks up in premarket as Wall Street weighs AI spend, lawsuit risk and demand
13 January 2026
1 min read

Tesla stock ticks up in premarket as Wall Street weighs AI spend, lawsuit risk and demand

New York, Jan 13, 2026, 09:01 EST — Premarket

  • After Monday’s close, Tesla shares edged up roughly 0.4% in premarket trading.
  • Wolfe Research pointed to potential pressure on 2026 profits due to increased AI spending but remained “tactically constructive.”
  • Investors are eyeing Tesla’s Jan. 28 earnings for signs on demand and profit margins.

Tesla shares edged up roughly 0.4% in premarket trading Tuesday, as investors weighed new analyst views on spending and demand ahead of the company’s upcoming earnings. The stock last traded near $451, following Monday’s close at $448.96.

This move is significant with Tesla’s next earnings report just around the corner. Traders are already adjusting their positions ahead of the quarterly results due on Jan. 28.

Wolfe Research analyst Emmanuel Rosner said he remains “tactically constructive” on Tesla but flagged that increased AI spending might pressure profits this year. He projects earnings per share of $1.84 in 2026 and expects Tesla’s electric-vehicle sales to hit 1.8 million units by then, according to Barron’s. Barron’s

Tesla is now hit with a class-action lawsuit claiming defective door handles on 2014–2016 Model S cars, according to Business Insider. The suit alleges the electronic handles can malfunction after a few years, posing safety risks in emergencies. Tesla has yet to respond to the allegations, the report added.

Policy changes are injecting fresh uncertainty into the U.S. EV sector. General Motors CEO Mary Barra maintained that EVs are still the industry’s “end game,” despite recent U.S. regulatory moves that scrapped the $7,500 EV tax credit, Reuters reported. Reuters

Tesla’s demand has shown signs of weakness this month. On Jan. 2, the company reported delivering 418,227 vehicles in Q4, a 15.6% drop compared to the same period last year, with full-year deliveries hitting roughly 1.64 million, according to Reuters.

Macro data also factored in, as investors weighed implications for rate forecasts and growth stocks. U.S. consumer prices increased 0.3% in December, maintaining a 2.7% annual pace, matching expectations, Reuters reported.

That said, the stock’s short-term outlook looks tight. Should price cuts deepen to counter slower demand following the drop in incentives, margins might suffer further. On top of that, increased spending could put even more strain on cash flow, making the trade-off harder to ignore.

Tesla’s next major event is its quarterly earnings report and conference call on Jan. 28. Investors will be watching closely for updates on pricing strategies, delivery targets for 2026, and progress with Full Self-Driving (FSD) — the company’s driver-assistance software available both as a package and subscription. Any changes to the timeline for its robotaxi plans will also be under scrutiny.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
ZIM stock edges up in premarket after a 52-week high run — what traders watch next
Previous Story

ZIM stock edges up in premarket after a 52-week high run — what traders watch next

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI
Next Story

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI

Go toTop